Western blotting and qPCR results further support this phenomenon that compared with the CONTROL group, the BC group had significantly decreased (P < 0.01) protein and mRNA expression of ZO-1 and occludin, while the LGR-1 + BC group had significantly increased (P < 0.001) protein and mRNA expression compared with BC group. The gene discussed is FSHR; the disease is breast cancer.